AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9567611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator circuit change every 5 days
Number of subjects: 78
Study 9567611 — intervention group
Group type: COMPARATOR
Intervention: Ventilator circuit change every 10 days
Number of subjects: 78
Study 9567611 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (5 days and 10 days)
Number of subjects: 78
Study 9567611 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who developed airway infection
Number of subjects: 78
Study 9567611 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who did not develop airway infection
Number of subjects: 78
Study 8187315 — intervention group
Group type: EXPERIMENTAL
Intervention: High insulin infusion (60 mU/kg/h)
Number of subjects: 8
Study 8187315 — intervention group
Group type: COMPARATOR
Intervention: Low insulin infusion (15 mU/kg/h)
Number of subjects: 8
Study 8187315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insulin levels
Number of subjects: 8
Study 2835977 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 1 (40% energy as carbohydrate, 10 g dietary fibre)
Number of subjects: 29
Study 2835977 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 2 (40% energy as carbohydrate, 52 g dietary fibre)
Number of subjects: 29
Study 2835977 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 3 (60% energy as carbohydrate, 84 g dietary fibre)
Number of subjects: 29
Study 30167741 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pedicle screw fixation (PPSF)
Number of subjects: 46
Study 30167741 — intervention group
Group type: COMPARATOR
Intervention: Open pedicle screw fixation (OPSF)
Number of subjects: 46
Study 31568799 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral maribavir treatment
Number of subjects: 120
Study 31568799 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 120
Study 31568799 — intervention group
Group type: COMPARATOR
Intervention: Maribavir
Number of subjects: 120
Study 31568799 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of F342Y and H411Y
Number of subjects: 120
Study 28787340 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic cuff pressure control based on subglottic CO2 levels
Number of subjects: 64
Study 28787340 — intervention group
Group type: COMPARATOR
Intervention: Manual cuff pressure management using a manometer 3 times/d
Number of subjects: 64
Study 26085289 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced nocturnal awakenings (FA)
Number of subjects: 62
Study 26085289 — intervention group
Group type: COMPARATOR
Intervention: Restricted sleep opportunity (RSO)
Number of subjects: 62
Study 26085289 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sleep (US)
Number of subjects: 62
Study 23835011 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch (HT) sessions three times per week for 6 weeks (n = 12)
Number of subjects: 19
Study 23835011 — intervention group
Group type: COMPARATOR
Intervention: Weekly friendly visits (FV) (n = 7)
Number of subjects: 19
Study 20655712 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendrobium candidum extract (DCEL) administered orally for 1 week
Number of subjects: 16
Study 20655712 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study 19450062 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin (5 mg/day)
Number of subjects: 0
Study 19450062 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine ER (4 mg/day)
Number of subjects: 0
Study 19450062 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 16439929 — intervention group
Group type: EXPERIMENTAL
Intervention: wallet-sized referral card
Number of subjects: 360
Study 16439929 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute nurse case management protocol
Number of subjects: 360
Study 12740260 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide, 250 mg bid
Number of subjects: 12
Study 12740260 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA), 30 mg bid
Number of subjects: 12
Study 10850938 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding with immune-enhancing diet (Impact with fiber) initiated < 72 hours after trauma
Number of subjects: 30
Study 10850938 — intervention group
Group type: COMPARATOR
Intervention: Delayed enteral feeding with immune-enhancing diet (Impact with fiber) administered after gastric ileus resolved
Number of subjects: 30
Study 9542722 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein breakfast
Number of subjects: 17
Study 9542722 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat breakfast
Number of subjects: 17
Study 9542722 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate breakfast
Number of subjects: 17
Study 9542722 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard breakfast
Number of subjects: 17
Study 9542722 — intervention group
Group type: COMPARATOR
Intervention: Fasting condition
Number of subjects: 17
Study 8380508 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 for 10 days (20 patients) commencing within 24‐48 hr of transplantation
Number of subjects: 41
Study 8380508 — intervention group
Group type: COMPARATOR
Intervention: ATGAM for 8 days (21 patients) commencing on the day of transplantation
Number of subjects: 41
Study 3706828 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone
Number of subjects: 14
Study 3706828 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 14
Study 3706828 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 14
Study 31906840 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D2 and calcium carbonate supplementation
Number of subjects: 18
Study 31906840 — intervention group
Group type: COMPARATOR
Intervention: Control group (only ART)
Number of subjects: 18
Study 29658501 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release implantable naltrexone
Number of subjects: 306
Study 29658501 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naltrexone
Number of subjects: 306
Study 29658501 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral and implant)
Number of subjects: 306
Study 27956679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 2924
Study 27956679 — intervention group
Group type: COMPARATOR
Intervention: No nitrous oxide
Number of subjects: 2924
Study 27956679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide in Asian patients
Number of subjects: 2924
Study 27956679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide with gene polymorphism
Number of subjects: 2924
Study 24606117 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual asenapine 10 mg
Number of subjects: 120
Study 24606117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 22371302 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.65 g/kg)
Number of subjects: 64
Study 22371302 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic placebo beverage
Number of subjects: 64
Study 20886804 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 3058
Study 18801887 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin concentrations (highest quintile > 9.8 microg/mL)
Number of subjects: 311
Study 16207605 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release nitrendipine microspheres
Number of subjects: 0
Study 16207605 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel pH-dependent gradient-release delivery system for nitrendipine
Number of subjects: 0
Study 16207605 — intervention group
Group type: COMPARATOR
Intervention: Domestic commercial nitrendipine tablets
Number of subjects: 0
Study 16207605 — intervention group
Group type: COMPARATOR
Intervention: Baypress nitrendipine tablets
Number of subjects: 0
Study 12648592 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete surgical staging including bilateral salpingo‐oophorectomy, hysterectomy, omentectomy, and pelvic and para‐aortic lymphadenectomy, followed by paclitaxel and carboplatin chemotherapy
Number of subjects: 20
Study 12648592 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin‐based chemotherapy following bilateral salpingo‐oophorectomy, hysterectomy, and omentectomy without lymphadenectomy
Number of subjects: 20
Study 11872915 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergent use of anticoagulants
Number of subjects: 0
Study 11872915 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin or other rapidly acting anticoagulants
Number of subjects: 0
Study 11872915 — intervention group
Group type: EXPERIMENTAL
Intervention: Early anticoagulation
Number of subjects: 0
Study 9853554 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI + TM group (10 patients)
Number of subjects: 20
Study 9853554 — intervention group
Group type: COMPARATOR
Intervention: PPI group (10 patients)
Number of subjects: 20
Study 7648234 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg nocte
Number of subjects: 49
Study 7648234 — intervention group
Group type: COMPARATOR
Intervention: Bezafibrate Slow Release (SR) 400 mg mane
Number of subjects: 49
Study 7648234 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined bezafibrate and simvastatin therapy
Number of subjects: 49
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty of right coronary artery occlusions
Number of subjects: 83
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty of left anterior descending artery occlusions
Number of subjects: 83
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up catheterization at 1 week for right coronary artery occlusions
Number of subjects: 83
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up catheterization at 1 week for left anterior descending artery occlusions
Number of subjects: 83
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty complications for right coronary artery occlusions
Number of subjects: 83
Study 2808974 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty complications for left anterior descending artery occlusions
Number of subjects: 83
Study 1178023 — intervention group
Group type: EXPERIMENTAL
Intervention: Low anti-HBs titer immune-serum globulin
Number of subjects: 712
Study 1178023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate high anti-HBs titer immune-serum globulin
Number of subjects: 712
Study 1178023 — intervention group
Group type: EXPERIMENTAL
Intervention: High anti-HBs titer immune-serum globulin
Number of subjects: 712
Study 1178023 — intervention group
Group type: COMPARATOR
Intervention: Control group (anti-HBs negative)
Number of subjects: 712
Study 1178023 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-HBs positive workers
Number of subjects: 712
Study 31024653 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom curriculum with MKSAP readings and weekly case discussions
Number of subjects: 98
Study 31024653 — intervention group
Group type: COMPARATOR
Intervention: Usual teaching (Control group)
Number of subjects: 98
Study 27155890 — intervention group
Group type: EXPERIMENTAL
Intervention: LM25
Number of subjects: 403
Study 27155890 — intervention group
Group type: EXPERIMENTAL
Intervention: LM50
Number of subjects: 403
Study 25994819 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab + Methotrexate (ADA + MTX)
Number of subjects: 0
Study 25994819 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 25994819 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (ADA)
Number of subjects: 0
Study 25994819 — intervention group
Group type: COMPARATOR
Intervention: Control group (MTX or ADA)
Number of subjects: 0
Study 23750860 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular CBT
Number of subjects: 40
Study 23750860 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 40
Study 21769617 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of levobupivacaine twice a day postoperatively via preperitoneal catheter
Number of subjects: 50
Study 21769617 — intervention group
Group type: COMPARATOR
Intervention: 10 ml of saline
Number of subjects: 50
Study 19596659 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion
Number of subjects: 5532
Study 19596659 — intervention group
Group type: COMPARATOR
Intervention: No transfusion (control group)
Number of subjects: 5532
Study 16522909 — intervention group
Group type: COMPARATOR
Intervention: Methionine intake of 0 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 16522909 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 5 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 16522909 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 10 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 16522909 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 15 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 16522909 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 25 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 16522909 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 35 mg.kg(‐1).d(‐1)
Number of subjects: 6
Study 15236826 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo beverage
Number of subjects: 0
Study 15236826 — intervention group
Group type: COMPARATOR
Intervention: Control beverage (nonalcoholic drink)
Number of subjects: 0
Study 10832517 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial orientation of lamellar stimuli
Number of subjects: 0
Study 10832517 — intervention group
Group type: EXPERIMENTAL
Intervention: Orientation of the plane containing the lamellar stimulus
Number of subjects: 0
Study 10832517 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrangement of enantiomorphic elements with respect to their axis of symmetry
Number of subjects: 0
Study 9335366 — intervention group
Group type: EXPERIMENTAL
Intervention: Recirculation type (RC) blood cardioplegia
Number of subjects: 0
Study 9335366 — intervention group
Group type: COMPARATOR
Intervention: Single pass type (SP) blood cardioplegia
Number of subjects: 0
Study 8446549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 613
Study 30113604 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (veneered abutments)
Number of subjects: 20
Study 30113604 — intervention group
Group type: COMPARATOR
Intervention: Control group (unveneered abutments)
Number of subjects: 20
Study 26613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitmore short stem
Number of subjects: 144
Study 26613788 — intervention group
Group type: COMPARATOR
Intervention: Cementless straight stem
Number of subjects: 144
Study 26613788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (short and straight stem)
Number of subjects: 144
Study 23884718 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mL/h intravenously with limited oral intake
Number of subjects: 311
Study 23884718 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mL/h intravenously with limited oral intake
Number of subjects: 311
Study 23884718 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mL/h intravenously with ad libitum oral intake of clear liquids
Number of subjects: 311
Study 22386286 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty
Number of subjects: 110
Study 22386286 — intervention group
Group type: COMPARATOR
Intervention: Uncoated balloon angioplasty
Number of subjects: 110
Study 19524265 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrografin (100 mL administered through a nasogastric tube)
Number of subjects: 110
Study 19524265 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gastrografin)
Number of subjects: 110
Study 18391715 — intervention group
Group type: COMPARATOR
Intervention: Normal population (control group)
Number of subjects: 60
Study 18391715 — intervention group
Group type: EXPERIMENTAL
Intervention: Isthmic spondylolisthesis (IS) population
Number of subjects: 60
Study 18391715 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of FJO between groups
Number of subjects: 60
Study 16316567 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous L-threonate plus placebo ferrous succinate
Number of subjects: 140
Study 16316567 — intervention group
Group type: COMPARATOR
Intervention: Ferrous succinate plus placebo ferrous L-threonate
Number of subjects: 140
Study 12032434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172
Study 12032434 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172
Study 12032434 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day triple therapy (proton pump inhibitor, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily)
Number of subjects: 172
Study 10472211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 15 min
Number of subjects: 10
Study 10472211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 30 min
Number of subjects: 10
Study 10472211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 infused over 15 min and 30 min
Number of subjects: 10
Study 7805928 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hFSH
Number of subjects: 123
Study 7805928 — intervention group
Group type: COMPARATOR
Intervention: Urinary hFSH
Number of subjects: 123
Study 1928007 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/d (400 IU/d) of vitamin D
Number of subjects: 52
Study 1928007 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms/d (800 IU/d) of vitamin D
Number of subjects: 52
Study 1928007 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 micrograms/d of 25-hydroxyvitamin D3
Number of subjects: 52
Study 1928007 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.85 micrograms/d of 25-hydroxyvitamin D3
Number of subjects: 52
Study 6137236 — intervention group
Group type: EXPERIMENTAL
Intervention: DAN 2%
Number of subjects: 8
Study 6137236 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 8
Study 6137236 — intervention group
Group type: EXPERIMENTAL
Intervention: DAN 0.5%
Number of subjects: 8
Study 6137236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol 2%
Number of subjects: 8
Study 31472419 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual house calls (VHCs)
Number of subjects: 36
Study 30384438 — intervention group
Group type: EXPERIMENTAL
Intervention: AboBoNT‐A (Dysport) injections (400 U) into the adductor muscles
Number of subjects: 46
Study 30384438 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 46
Study 26732111 — intervention group
Group type: EXPERIMENTAL
Intervention: Various surgical techniques for varicocele correction
Number of subjects: 0
Study 26732111 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 24881631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 391
Study 24881631 — intervention group
Group type: COMPARATOR
Intervention: Ofatumumab
Number of subjects: 391
Study 22267183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (8 weeks)
Number of subjects: 19
Study 22267183 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison subjects (N=21)
Number of subjects: 19
Study 21152458 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education (counselling and written instructions)
Number of subjects: 38
Study 21152458 — intervention group
Group type: COMPARATOR
Intervention: Control group (clear liquid diet and 4 L of bowel preparation without additional education)
Number of subjects: 38
Study 17927832 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 351
Study 17927832 — intervention group
Group type: EXPERIMENTAL
Intervention: DTSQc
Number of subjects: 351
Study 17927832 — intervention group
Group type: COMPARATOR
Intervention: DTSQs
Number of subjects: 351
Study 17927832 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived Hyper- and Hypoglycaemia
Number of subjects: 351
Study 15020520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil 25 mg
Number of subjects: 38
Study 15020520 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide 10.5 mg
Number of subjects: 38
Study 15020520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 11910715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration solution (ORS) ad libitum (AL group)
Number of subjects: 80
Study 11910715 — intervention group
Group type: COMPARATOR
Intervention: Oral rehydration solution (ORS) in fractionated doses (FD group)
Number of subjects: 80
Study 11910715 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of ORS intake, rehydration time, and mean diuresis values
Number of subjects: 80
Study 9824019 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid‐Vent Filter Light HMEF
Number of subjects: 136
Study 9824019 — intervention group
Group type: COMPARATOR
Intervention: Pall BB 100 HMEF
Number of subjects: 136
Study 8131020 — intervention group
Group type: EXPERIMENTAL
Intervention: Local pathology
Number of subjects: 0
Study 8131020 — intervention group
Group type: EXPERIMENTAL
Intervention: Review pathology
Number of subjects: 0
Study 2782271 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22
Study 2782271 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 22
Study 1097866 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya bean milk (150 ml second-hourly from 7 a.m. to 11 p.m. daily for two weeks)
Number of subjects: 10
Study 1097866 — intervention group
Group type: COMPARATOR
Intervention: Control group (no soya bean milk therapy)
Number of subjects: 10
Study 1097866 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya bean milk
Number of subjects: 10
Study 1097866 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 31287135 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of spina bifida among mothers
Number of subjects: 38
Study 31287135 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of medications during pregnancy
Number of subjects: 38